Covered recipient · General Payments record
ALAN ALEXANDER ARISMENDEZ
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,847.71
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $695.27 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $369.89 | 18 |
| Neurelis, Inc. | $70.69 | 3 |
| JAZZ PHARMACEUTICALS INC. | $62.32 | 2 |
| ARGENX US, INC. | $53.22 | 2 |
| PFIZER INC. | $47.25 | 2 |
| UCB, Inc. | $41.97 | 1 |
| SK Life Science, Inc. | $30.43 | 1 |
| Lilly USA, LLC | $19.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.86 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238763 | CMS |
| ABBVIE INC. | $19.33 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238765 | CMS |
| ABBVIE INC. | $15.45 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238767 | CMS |
| ABBVIE INC. | $24.86 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238769 | CMS |
| ABBVIE INC. | $15.90 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238771 | CMS |
| ABBVIE INC. | $16.44 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238773 | CMS |
| ABBVIE INC. | $15.56 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238775 | CMS |
| ABBVIE INC. | $29.64 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238777 | CMS |
| ABBVIE INC. | $23.68 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238779 | CMS |
| ABBVIE INC. | $16.30 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238781 | CMS |
| ABBVIE INC. | $13.81 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238783 | CMS |
| ABBVIE INC. | $24.00 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238785 | CMS |
| ABBVIE INC. | $18.02 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238787 | CMS |
| ABBVIE INC. | $23.15 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238789 | CMS |
| ABBVIE INC. | $30.14 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238791 | CMS |
| ABBVIE INC. | $18.23 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238793 | CMS |
| ABBVIE INC. | $15.79 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238795 | CMS |
| ABBVIE INC. | $32.73 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103238797 | CMS |
| ARGENX US, INC. | $23.04 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142109567 | CMS |
| ARGENX US, INC. | $30.18 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142125135 | CMS |
| JAZZ PHARMACEUTICALS INC. | $36.21 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150228801 | CMS |
| JAZZ PHARMACEUTICALS INC. | $26.11 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150228803 | CMS |
| Lilly USA, LLC | $19.50 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136014004 | CMS |
| Neurelis, Inc. | $20.24 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145631873 | CMS |
| Neurelis, Inc. | $26.18 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145631877 | CMS |
| Neurelis, Inc. | $24.27 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145631882 | CMS |
| PFIZER INC. | $29.70 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131436734 | CMS |
| PFIZER INC. | $17.55 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132104968 | CMS |
| SK Life Science, Inc. | $30.43 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154117808 | CMS |
| UCB, Inc. | $41.97 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143149941 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.